Citations

Mayo Clinic

Showing 10 of 108572 citations.

TGF-β inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors
Gao, Xiaofei , Lee, Hsiang‐Ying , Rocha, Edroaldo Lummertz da , Zhang, Cheng , Lu, Yi-Fen , Feng, Yuxiong , Ezike, Jideofor , Elmes, Russell R., Barrasa, M. Inmaculada , Cahan, Patrick , Hu, Li , Daley, George Q. , Lodish, Harvey F. , da Rocha, Edroaldo Lummertz, Li, Dandan , Zhang, Cheng

Blood | October 24, 2016 | Volume: 128 | Issue: 23 | Pages: 2637-2641

10.1182/blood-2016-05-718320 | PMID 27777239 Get It

Key Points The type III TGF-β receptor is a marker that distinguishes “early” and “late” BFU-Es. TGF-β inhibitors increase early BFU-E cell self-renewal and total erythroblast production.
Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology
Kopecky, Stephen L. , Bauer, Douglas C. , Gulati, Martha , Nieves, Jeri W. , Singer, Andrea , Tóth, Peter P. , Underberg, James , Wallace, Taylor C. , Singer, Andrea J, Underberg, James A, Weaver, Connie M. , Bauer, Douglas C

Annals of Internal Medicine | October 24, 2016 | Volume: 165 | Issue: 12 | Pages: 867-868

10.7326/m16-1743 | PMID 27776362 Get It

A Proposal for a Serology-Based Approach to Membranous Nephropathy
Vriese, An S. De , Glassock, Richard J. , Nath, Karl A. , Sethi, Sanjeev , Fervenza, Fernando C. , De Vriese, An S

Journal of the American Society of Nephrology | October 24, 2016 | Volume: 28 | Issue: 2 | Pages: 421-430

10.1681/asn.2016070776 | PMID 27777266 Get It

Primary membranous nephropathy (MN) is an autoimmune disease mainly caused by autoantibodies against the recently discovered podocyte antigens: the M-type phospholipase A2 receptor 1 (PLA2R) and thrombospondin type 1 domain-containing 7A (THSD7A). Assays for quantitative assessment of anti-PLA2R antibodies are commercially available, but a semiquantitative test to detect anti-THSD7A antibodies has been only recently developed. The presence or absence of anti-PLA2R and anti-THSD7A antibodies adds important information to clinical and immunopathologic data in discriminating between primary and secondary MN. Levels of anti-PLA2R antibodies and possibly, anti-THSD7A antibodies tightly correlate with disease activity. Low baseline and decreasing anti-PLA2R antibody levels strongly predict spontaneous remission, thus favoring conservative therapy. Conversely, high baseline or increasing anti-PLA2R antibody levels associate with nephrotic syndrome and progressive loss of kidney function, thereby encouraging prompt initiation of immunosuppressive therapy. Serum anti-PLA2R antibody profiles reliably predict response to therapy, and levels at completion of therapy may forecast long-term outcome. Re-emergence of or increase in antibody titers precedes a clinical relapse. Persistence or reappearance of anti-PLA2R antibodies after kidney transplant predicts development of recurrent disease. We propose that an individualized serology-based approach to MN, used to complement and refine the traditional proteinuria-driven approach, will improve the outcome in this disease.
Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function
Heilman, Raymond L. , Qaqish, Ibrahim , Khamash, Hasan , Singer, Andrew L., Reddy, Kunam S. , Smith, Maxwell L. , Smith, Byron H. , Kaplan, Bruce

Clinical Journal of the American Society of Nephrology | October 24, 2016 | Volume: 11 | Issue: 12 | Pages: 2225-2232

10.2215/cjn.05060516 | PMID 27797897 Get It

Background and objectives Delayed graft function is a form of AKI resulting from ischemia-reperfusion injury. Our aim was to study the effect of delayed graft function on the progression of interstitial fibrosis after deceased donor kidney transplantation. Design, setting, participants, & measurements Our study is a retrospective study of all patients transplanted at our center between July of 2003 and September of 2014 using a kidney from a deceased donor. The primary outcome was the progression of interstitial fibrosis on serial protocol biopsies done during the first year post-transplant. We analyzed the distribution of the change in the Banff interstitial fibrosis (ci) score between the delayed graft function and nondelayed graft function groups for all of the paired biopsies done at time 0 and 12 months post-transplant ( Δ fibrosis). We also performed a linear mixed model analyzing the difference in the slopes for the progression of mean Banff ci score for all of the biopsies done at time 0 and 1, 4, and 12 months post-transplant. Results There were 343 (36.7%) in the delayed graft function group and 591 in the control group. The biopsy rates for the delayed graft function and nondelayed graft function groups at time 0 were 65.3% ( n =224) and 67.0% ( n =396), respectively, and at 12 months, they were 64.4% ( n =221) and 68.4% ( n =404), respectively. Paired biopsies were available for 155 in the delayed graft function group and 283 in the control group. In a risk-adjusted model, Banff ci score >0 on the time 0 biopsy had a higher odds of delayed graft function (odds ratio, 1.70; 95% confidence interval, 1.03 to 2.82). The distribution of the Δ fibrosis between 0 and 12 months was similar in delayed graft function and control groups ( P =0.91). The slopes representing the progression of fibrosis were also similar between the groups ( P =0.66). Conclusions Donor-derived fibrosis may increase the odds of delayed graft function; however, delayed graft function does not seem to increase the progression of fibrosis during the first year after transplantation.
Comparison of Open Drainage Versus Closed Catheter Irrigation for Treatment of Suppurative Flexor Tenosynovitis
Born, Trevor, Wagner, Eric R. , Born, Trevor R, Kakar, Sanjeev , Wagner, Eric R

HAND | October 24, 2016 | Volume: 12 | Issue: 6 | Pages: 579-584

10.1177/1558944716675131 | PMID 29091483 Get It

Background: The purpose of this study was to review the outcomes associated with different surgical treatments in the management of suppurative flexor tenosynovitis (SFT). Methods: Patients treated by open drainage (OD) through a single incision and closed catheter irrigation (CCI) of the tendon sheath were evaluated from 2003 to 2009 at a single institution. Variables examined included culture results, time to surgery, duration of hospitalization and antibiotic therapy, pain, reoperation, and functional outcomes were recorded. Statistical analyses used included parametric and nonparametric t tests. Results: Twenty-four patients were treated for SFT with a mean follow-up of 3 ± 2 years. There were 13 (100%) males in the OD group compared to 8 (72%) males within the CCI group. Ninety-two percent of patients who underwent OD and 100% who underwent CCI reported none or mild pain. There were no differences between the 2 groups with regard to functional outcome scores. Factors leading to worse functional outcomes included prolonged time to receiving antibiotics and Staphylococcus aureus infection. Smokers required prolonged antibiotic treatment compared to nonsmokers. Accounting for planned returns to the operating room, there was no difference in reoperation rates between the OD or CCI groups. Conclusions: Surgical treatment of SFT with either OD or CCI resulted in similar outcomes for pain, function, and need for reoperation. Factors that lead to poor outcomes include S aureus culture, prolonged time to antibiotics, and smoking.
Abstract B41: Cell-contact dependent epithelial-stromal cross talk, including a modulation of stromal PDGFR expression, drives the progression of early-stage breast cancer lesions
Paulsson, Janna, Jin, Shaobo , Roswall, Pernilla, Johanna, Andrea, Frings, Oliver , Warnberg, Fredrick, Johansson, Hemming , Östman, Arne , Strell, Carina , Mezheyeuski, Artur , Jirström, Karin , Pietras, Kristian , Hall, Per N , Lendahl, Urban , Betsholtz, Christer , Radisky, Derek C.

Cancer Research | October 24, 2016 | Volume: 76 | Issue: 15_Supplement | Pages: B41-B41

10.1158/1538-7445.tme16-b41 Get It

Abstract We have investigated the distribution of PDGFR-a and -b in the stroma of normal breast tissue, ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) by immunohistochemistry. Both receptors were expressed by fibroblasts of normal breast tissue. While the PDGFRb remained high during cancer progression, the PDGFRa was lost in most of the DCIS samples and not detectable in IDC. The patient group with PDGFRa(low)/PDGFRb(high) fibroblasts had the highest risk for local recurrences or metastasis. The characteristic loss of stromal PDGFRa expression was also observed in the PyMT mouse breast cancer model. In vitro co-culture experiments confirmed a tumor cell-induced differentiation of fibroblasts, resulting in a fibroblast population marked by PDGFRa(low)/PDGFRb(high) expression. We could identify the interaction of Jagged-1 expressed by the tumor cells with Notch-2 expressed on the fibroblasts, as an essential activator of TGFb signaling in fibroblasts. Gene expression analysis and reporter-gene assays of sorted cells from co-cultures revealed, that fibroblasts switch from a more anti-tumorigenic signaling (expression of BMPs and Wnt antagonists) towards a pro-tumorigenic signaling (expression of BMP inhibitors, TGFb and Wnt ligands). Co-cultured tumor cells show an increased migratory activity and the induction of a mesenchymal phenotype. Inhibition of Notch or TGF signaling in fibroblasts could block these phenotypes. To investigate the impact of fibroblasts on the progression of DCIS to IDC, a DCIS xenograft model was used. Co-injection of MCF10.DCIS cells with human breast fibroblasts, expressing both PDGFRs, into the mouse mammary fat pad resulted in an earlier tumor take with faster tumor growth. The corresponding co-injection experiments with fibroblast and tumor cells, that were depleted of Notch2 respectively Jagged-1 expression by CRISPR/CAS technology is currently ongoing. Collectively the study identifies a potentially druggable paracrine cross-talk between epithelial and stromal cells, which promotes DCIS progression and involves a Notch mediated up-regulation of TGFb signaling. The study also suggests that loss of PDGFRa marks a subset of fibroblasts with specific tumor-promoting activities. Citation Format: Carina Strell, Janna Paulsson, Artur Mezheyeuski, Shao-Bo Jin, Pernilla Roswall, Johanna Andrea, Oliver Frings, Fredrick Warnberg, Hemming Johansson, Karin Jirstrom, Kristian Pietras, Per Hall, Urban Lendahl, Christer Betsholtz, Derek C. Radisky, Arne Ostman. Cell-contact dependent epithelial-stromal cross talk, including a modulation of stromal PDGFR expression, drives the progression of early-stage breast cancer lesions. [abstract]. In: Proceedings of the AACR Special Conference: Function of Tumor Microenvironment in Cancer Progression; 2016 Jan 7–10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2016;76(15 Suppl):Abstract nr B41.
Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
Way, Gregory P. , Rudd, James , Hamidi, Habib , Konecny, Gottfried E. , Goode, Ellen L. , Greene, Casey S. , Doherty, Jennifer A. , Greene, Casey S , Doherty, Jennifer A , Wang, Chen , Fridley, Brooke L.

G3 Genes|Genomes|Genetics | October 24, 2016 | Volume: 6 | Issue: 12 | Pages: 4097-4103

10.1534/g3.116.033514 | PMID 27729437 Get It

Abstract Four gene expression subtypes of high-grade serous ovarian cancer (HGSC) have been previously described. In these early studies, a fraction of samples that did not fit well into the four subtype classifications were excluded. Therefore, we sought to systematically determine the concordance of transcriptomic HGSC subtypes across populations without removing any samples. We created a bioinformatics pipeline to independently cluster the five largest mRNA expression datasets using k-means and nonnegative matrix factorization (NMF). We summarized differential expression patterns to compare clusters across studies. While previous studies reported four subtypes, our cross-population comparison does not support four. Because these results contrast with previous reports, we attempted to reproduce analyses performed in those studies. Our results suggest that early results favoring four subtypes may have been driven by the inclusion of serous borderline tumors. In summary, our analysis suggests that either two or three, but not four, gene expression subtypes are most consistent across datasets.
Use of the American Urological Association Clinical Practice Guidelines: Data from the AUA Census
Meeks, William, Lightner, Deborah J., Lightner, Deborah, Breyer, Benjamin N. , Fang, Raymond S. , Clemens, J. Quentin

Urology Practice | October 24, 2016 | Volume: 4 | Issue: 6 | Pages: 462-467

10.1016/j.urpr.2016.10.003 | PMID 37300134 Get It

A Survey of Perceptions and Acceptance of Wearable Technology for Health Monitoring in a Urological Patient Population
Nehra, Avinash , Gettman, Matthew T., Rivera, Marcelino , Agarwal, Deepak , O’Neil, Daniel A. , Jenkins, Sarah M. , Tollefson, Matthew K. , Viers, Boyd R. , Nehra, Avinash K, Rivera, Marcelino E, Agarwal, Deepak K, Viers, Boyd R

Urology Practice | October 24, 2016 | Volume: 4 | Issue: 6 | Pages: 508-514

10.1016/j.urpr.2016.10.002 | PMID 37300143 Get It